CD109 and systemic sclerosis: Our preliminary results demonstrating that CD109 protein degradation is impaired in SSc fibroblasts (AB and AP, 2012, unpublished results) suggest that impaired CD109 degradation may be responsible for the elevated CD109 protein levels in SSc fibroblasts.